Lipoprotein-apolipoprotein changes in renal transplant recipients

Maurizio Cassader, Gianluca Ruiu, Roberto Gambino, Natalina Alemanno, Giorgio Triolo, Fabrizio Veglia, Gianfranco Pagano

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Recent studies have demonstrated that the incidence of cardiovascular events occurring with renal transplantation is higher than that in the general population. Renal transplantation modifies the characteristic dyslipidemia of chronic renal failure. In this study the change in lipoprotein and lipid values of 103 transplant recipients after transplantation was investigated. The aim of our work was to examine the short-term and long-term variations in lipid metabolism. The major lipoprotein fractions (VLDL, LDL, HDL) were separated by preparative ultracentrifugation, and TG and cholesterol concentrations were determined in plasma and lipoprotein fractions. Whole plasma apolipoproteins were determined by a rate immunonephelometric technique. In the pretransplant period the patients displayed the typical picture of uremics. After transplantation the most evident alterations in the lipoprotein profile occurred in our case series after 3 mon. The major finding was a 35% reduction in plasma TG. The modifications in the TG-rich lipoproteins of our transplant recipients persisted throughout the observation period. In the initial 3-mon period, total cholesterol remained steady, whereas LDL-cholesterol and total apolipoprotein B showed a significant increase. No significant changes were found in total and transported TG and cholesterol between the 3-mon and the 6-yr values. The substantial stability of cholesterol levels after transplantation and in subsequent reports, as well as a higher incidence of cardiovascular complications, may suggest that the mechanisms responsible for vessel damage must be sought mainly in the structural and physicochemical alterations of the individual lipoprotein fractions or in other risk factors.

Original languageEnglish
Pages (from-to)967-974
Number of pages8
JournalLipids
Volume37
Issue number10
DOIs
Publication statusPublished - Oct 1 2002

Fingerprint

kidney transplant
Transplants
apolipoproteins
Apolipoproteins
lipoproteins
Lipoproteins
Kidney
Cholesterol
cholesterol
Transplantation
Kidney Transplantation
Plasmas
VLDL Lipoproteins
Transplantation (surgical)
Ultracentrifugation
Incidence
Apolipoproteins B
incidence
apolipoprotein B
Dyslipidemias

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Food Science
  • Biochemistry

Cite this

Cassader, M., Ruiu, G., Gambino, R., Alemanno, N., Triolo, G., Veglia, F., & Pagano, G. (2002). Lipoprotein-apolipoprotein changes in renal transplant recipients. Lipids, 37(10), 967-974. https://doi.org/10.1007/s11745-006-0988-x

Lipoprotein-apolipoprotein changes in renal transplant recipients. / Cassader, Maurizio; Ruiu, Gianluca; Gambino, Roberto; Alemanno, Natalina; Triolo, Giorgio; Veglia, Fabrizio; Pagano, Gianfranco.

In: Lipids, Vol. 37, No. 10, 01.10.2002, p. 967-974.

Research output: Contribution to journalArticle

Cassader, M, Ruiu, G, Gambino, R, Alemanno, N, Triolo, G, Veglia, F & Pagano, G 2002, 'Lipoprotein-apolipoprotein changes in renal transplant recipients', Lipids, vol. 37, no. 10, pp. 967-974. https://doi.org/10.1007/s11745-006-0988-x
Cassader M, Ruiu G, Gambino R, Alemanno N, Triolo G, Veglia F et al. Lipoprotein-apolipoprotein changes in renal transplant recipients. Lipids. 2002 Oct 1;37(10):967-974. https://doi.org/10.1007/s11745-006-0988-x
Cassader, Maurizio ; Ruiu, Gianluca ; Gambino, Roberto ; Alemanno, Natalina ; Triolo, Giorgio ; Veglia, Fabrizio ; Pagano, Gianfranco. / Lipoprotein-apolipoprotein changes in renal transplant recipients. In: Lipids. 2002 ; Vol. 37, No. 10. pp. 967-974.
@article{6935766ff21a483bb0ef2d8fd814e981,
title = "Lipoprotein-apolipoprotein changes in renal transplant recipients",
abstract = "Recent studies have demonstrated that the incidence of cardiovascular events occurring with renal transplantation is higher than that in the general population. Renal transplantation modifies the characteristic dyslipidemia of chronic renal failure. In this study the change in lipoprotein and lipid values of 103 transplant recipients after transplantation was investigated. The aim of our work was to examine the short-term and long-term variations in lipid metabolism. The major lipoprotein fractions (VLDL, LDL, HDL) were separated by preparative ultracentrifugation, and TG and cholesterol concentrations were determined in plasma and lipoprotein fractions. Whole plasma apolipoproteins were determined by a rate immunonephelometric technique. In the pretransplant period the patients displayed the typical picture of uremics. After transplantation the most evident alterations in the lipoprotein profile occurred in our case series after 3 mon. The major finding was a 35{\%} reduction in plasma TG. The modifications in the TG-rich lipoproteins of our transplant recipients persisted throughout the observation period. In the initial 3-mon period, total cholesterol remained steady, whereas LDL-cholesterol and total apolipoprotein B showed a significant increase. No significant changes were found in total and transported TG and cholesterol between the 3-mon and the 6-yr values. The substantial stability of cholesterol levels after transplantation and in subsequent reports, as well as a higher incidence of cardiovascular complications, may suggest that the mechanisms responsible for vessel damage must be sought mainly in the structural and physicochemical alterations of the individual lipoprotein fractions or in other risk factors.",
author = "Maurizio Cassader and Gianluca Ruiu and Roberto Gambino and Natalina Alemanno and Giorgio Triolo and Fabrizio Veglia and Gianfranco Pagano",
year = "2002",
month = "10",
day = "1",
doi = "10.1007/s11745-006-0988-x",
language = "English",
volume = "37",
pages = "967--974",
journal = "Lipids",
issn = "0024-4201",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Lipoprotein-apolipoprotein changes in renal transplant recipients

AU - Cassader, Maurizio

AU - Ruiu, Gianluca

AU - Gambino, Roberto

AU - Alemanno, Natalina

AU - Triolo, Giorgio

AU - Veglia, Fabrizio

AU - Pagano, Gianfranco

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Recent studies have demonstrated that the incidence of cardiovascular events occurring with renal transplantation is higher than that in the general population. Renal transplantation modifies the characteristic dyslipidemia of chronic renal failure. In this study the change in lipoprotein and lipid values of 103 transplant recipients after transplantation was investigated. The aim of our work was to examine the short-term and long-term variations in lipid metabolism. The major lipoprotein fractions (VLDL, LDL, HDL) were separated by preparative ultracentrifugation, and TG and cholesterol concentrations were determined in plasma and lipoprotein fractions. Whole plasma apolipoproteins were determined by a rate immunonephelometric technique. In the pretransplant period the patients displayed the typical picture of uremics. After transplantation the most evident alterations in the lipoprotein profile occurred in our case series after 3 mon. The major finding was a 35% reduction in plasma TG. The modifications in the TG-rich lipoproteins of our transplant recipients persisted throughout the observation period. In the initial 3-mon period, total cholesterol remained steady, whereas LDL-cholesterol and total apolipoprotein B showed a significant increase. No significant changes were found in total and transported TG and cholesterol between the 3-mon and the 6-yr values. The substantial stability of cholesterol levels after transplantation and in subsequent reports, as well as a higher incidence of cardiovascular complications, may suggest that the mechanisms responsible for vessel damage must be sought mainly in the structural and physicochemical alterations of the individual lipoprotein fractions or in other risk factors.

AB - Recent studies have demonstrated that the incidence of cardiovascular events occurring with renal transplantation is higher than that in the general population. Renal transplantation modifies the characteristic dyslipidemia of chronic renal failure. In this study the change in lipoprotein and lipid values of 103 transplant recipients after transplantation was investigated. The aim of our work was to examine the short-term and long-term variations in lipid metabolism. The major lipoprotein fractions (VLDL, LDL, HDL) were separated by preparative ultracentrifugation, and TG and cholesterol concentrations were determined in plasma and lipoprotein fractions. Whole plasma apolipoproteins were determined by a rate immunonephelometric technique. In the pretransplant period the patients displayed the typical picture of uremics. After transplantation the most evident alterations in the lipoprotein profile occurred in our case series after 3 mon. The major finding was a 35% reduction in plasma TG. The modifications in the TG-rich lipoproteins of our transplant recipients persisted throughout the observation period. In the initial 3-mon period, total cholesterol remained steady, whereas LDL-cholesterol and total apolipoprotein B showed a significant increase. No significant changes were found in total and transported TG and cholesterol between the 3-mon and the 6-yr values. The substantial stability of cholesterol levels after transplantation and in subsequent reports, as well as a higher incidence of cardiovascular complications, may suggest that the mechanisms responsible for vessel damage must be sought mainly in the structural and physicochemical alterations of the individual lipoprotein fractions or in other risk factors.

UR - http://www.scopus.com/inward/record.url?scp=0036819279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036819279&partnerID=8YFLogxK

U2 - 10.1007/s11745-006-0988-x

DO - 10.1007/s11745-006-0988-x

M3 - Article

C2 - 12530556

AN - SCOPUS:0036819279

VL - 37

SP - 967

EP - 974

JO - Lipids

JF - Lipids

SN - 0024-4201

IS - 10

ER -